Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what estimate he has made of potential savings to the NHS arising from an expansion of the availability of Take-Home Naloxone.

No estimate has been made of the potential savings to the National Health Service arising from expanding the availability of take-home naloxone.

The Advisory Council on the Misuse of Drugs’ ‘Consideration of naloxone’ (2012) reported that there is a lack of published research on the cost-effectiveness of naloxone provision and said that naloxone provision in local areas would be a local decision including an assessment of its cost-effectiveness.

To help local areas introduce effective and efficient take-home services, Public Health England published advice on promoting wider availability of naloxone to reduce overdose deaths in February 2015.